Navigation Links
Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award Conferred on LaGray Chemical Company
Date:2/3/2010

LONDON, Feb. 3 /PRNewswire/ -- The 2009 Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award is presented to LaGray Chemical Company, the first local Ghanaian company to manufacture Active Pharmaceutical Ingredients (APIs). Adhering to Good Manufacturing Practices, LaGray Chemical Company's manufacturing capacity includes 10 metric tonnes of API, 8 million laminated aluminum tubes of dermatological products, 300 million oral capsules and 150 million tablets per annum.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

LaGray Chemical Company was established in 2000 and commercial production commenced in 2007 with a strong focus on pharmaceuticals for the treatment of endemic diseases. The company's vertical strategy to fulfill the complete value chain of pharmaceutical production (manufacturing APIs for the production of the complete products) has proven its innovativeness to grow in the Ghanaian pharmaceutical industry and to successfully expand in the remaining parts of West Africa.  

"With a few Ghanaian pharmaceutical manufacturers struggling to retool in order to achieve the World Health Organization (WHO) pre-qualification, LaGray Chemical Company's position is advancing above its competitors because its facilities and systems have been designed toward that objective, right from inception," states Frost & Sullivan Research Analyst Lizelle Wentzel. "The company's current products are filed in 15 sub-Saharan African countries."  

The current product portfolio includes Azithromycin (production commenced in August 2008) dermatologicals and anti-infectives. Furthermore, the company has anti-retrovirals, anti-malarials and antihypertensives in the pipeline for 2010.

"LaGray Chemical Company strives to become an affordable pharmaceutical manufacturer that would not only supply drugs but also diagnostics and vaccines in future," remarks Wentzel.  "It strengthened its position strategically by entering a technology transfer agreement with an Indian company in 2007; this agreement allowed the company to access synthetic intermediates used during the production of APIs."

Apart from the key disease burdens in Ghana and the remaining countries of the sub-region, West Africa has various priority endemic diseases (PED) that are currently not optimally addressed due to the lack of treatment products in most instances. With the PEDs a focus for the Ghanaian government, LaGray Chemical Company is using this demand as a key opportunity for growth and expansion.  

"LaGray Chemical Company is still in its early growth phase but is considered to be the most innovative local manufacturing company participating in Ghana's pharmaceutical industry," concludes Wentzel. "With the company only starting its endeavour, it is expected that it will continue to increase its market presence through the continuous production of quality pharmaceutical products that effectively address the needs of the market."

The Frost & Sullivan Award for Industry Innovation & Advancement is bestowed upon the company that has proven to be a leader in the industry and that, through its pioneering technology, sound business strategy, and research efforts, has been successful in moving the state of the industry forward.  Its excellence in the field has extended beyond its technical advancements and encompasses a comprehensive view of market participants, resulting in an ongoing improvement in the industry over time.  This Award recognizes the company for its broader, more comprehensive participation in the industry and for its contributions to the advancement of the market.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About LaGray Chemical Company

LaGray Chemical Company (www.lagraychem.com) is the first vertically integrated pharmaceutical manufacturing company in West Africa. From concept to implementation, the company was built to be compliant with international standards of Good Manufacturing Practices for pharmaceuticals. The company produces medicines to treat serious endemic diseases and for improving the quality of life in West Africa. The founders of the company have years of experience working for major multinational companies and have brought their experience back to the region.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

Contact:

Ciara Jamie Connolly, Senior Events & Promotions Executive/EMEA, Best Practices, Frost & Sullivan, ciara.connolly@frost.com, P: 0044 (0) 207.915.7868, F: 0044 (0) 207.730.3343, www.frost.com

SOURCE Frost & Sullivan

RELATED LINKS
http://www.frost.com

'/>"/>

SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Frost & Sullivan to Hold Web Conference on Integrated Hospital Pharmacy Information Systems - How to Maneuver towards Growth Potential
2. Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies
3. Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan
4. Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe, Finds Frost & Sullivan
5. Frost & Sullivan to Hold Analyst Briefing on the European Neurophysiological Monitoring Market, the Golden Standard in Patient Safety
6. Frost & Sullivan to Discuss Investment Patterns in the Healthcare Industry in Free Webinar
7. Parenting Expert and Family Advocate Jo Frost and Allergy & Asthma Network Mothers of Asthmatics (AANMA) Launch Time 2 Talk Asthma
8. Frost & Sullivan: Key Therapeutic Areas to Remain Strongest Drivers of CRO Revenue Growth in the United States
9. Prescient Medical vProtect(TM) Luminal Shield Receives North American Product Innovation of the Year Award from Frost & Sullivan
10. Medical Imaging Equipment Finds Significant Uptake in Ghana, Finds Frost & Sullivan
11. Frost & Sullivan: First Responders Communication Interoperability - A Vital Need for Life-Saving Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... Allegheny Health Network ... The Alexis Joy D’Achille Center for Women’s Behavioral Health at West Penn Hospital ... western Pennsylvania for women suffering from pregnancy-related depression. Construction of the Center is ...
(Date:5/23/2017)... ... 23, 2017 , ... New England Journal Of Medicine Confirms Viability of Rory’s ... -The Rory Staunton Foundation Calls on Health & Human Services, Tom Price to Adopt ... http://www.rorystauntonfoundation.org ) today reported on a new study released on May 21, 2017 in ...
(Date:5/23/2017)... Newport Beach, CA (PRWEB) , ... May 23, 2017 , ... ... Capital Partners was honored to serve earlier this month as a Guest Speaker and ... by the British Royal Family and Common Purpose. , Walter Schindler ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... educating patients on peri-implantitis in Las Vegas, NV, and the importance ... custom gum disease consultation and leading care for peri-implantitis, with or without a ...
(Date:5/23/2017)... ... May 23, 2017 , ... New patients from Charleston, SC, are ... dentist practicing in Mt. Pleasant, SC, with or without a referral. A full mouth ... with missing teeth in Charleston, SC. Those who suffer from gum disease, ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... 2017 MACRA replaces the outdated sustainable ... service reimbursement. Black Book Research crowdsource-surveyed 8,845 physician practices ... The Market for MIPS Compliance Technology is Booming ... with 3 or more clinicians seek to buy Merit-Based ... the magnitude of the changes, the hunt is on ...
(Date:5/6/2017)... N.Y. , May 5, 2017  Hill-Rom Holdings, ... will add approximately 100,000 square feet to its Welch ... September 2016 its commitment to bring more than 100 ... , where Welch Allyn has maintained a significant presence ... help accommodate these new positions, a large portion of ...
(Date:5/4/2017)... LAWRENCE, Mass. and SAN DIEGO ... of Obstetricians and Gynecologists (ACOG) 2017 Annual Clinical and ... of single-use, self-contained, illuminating medical devices, today announced the ... size of its OfficeSPEC and ER-SPEC ... large, the addition of extra-small and extra-large sizes makes ...
Breaking Medicine Technology: